COVID-19 Vaccine Pill Set
to Enter Clinical Trials .
Oravax is developing a
COVID-19 vaccine to be
administered in pill form.
It hopes to begin human clinical trials by June.
Oravax's venture will be joined by Israeli-American company Oramed and Indian company Premas Biotech.
According to Nadav Kidron, CEO of Oramed, an oral vaccine could "potentially [enable] people to take the vaccine themselves at home.".
The vaccine could also be stored at room temperature after being shipped in a regular refrigerator, .
"making it logistically easier to get it anywhere around the world," Kidron said.
Other companies are attempting
to develop second-generation
vaccines as well, including
oral and nasal versions.
More research and testing is required
for all of the potential vaccines